Hundreds of denim-clad guests (the invite said Genes=Jeans, welcoming, even encouraging, denim) filled the Dolce Events venue ...

Jaime King opened up about her emotional experience wearing a bald cap for her ‘Love, Danielle’ role in an exclusive ...

One of the biggest challenges in cancer treatment is chemoresistance: Tumors that initially respond well to chemotherapy ...

The institute reports that more than 60% of women who inherit a harmful variant in BRCA1 or BRCA2 will develop breast cancer ...

Hereditary breast cancer due to genetic mutations accounts for 5% to 10% of breast cancers. Breast cancer is the most ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

FORMS, AND YOU MAY HAVE HEARD OF SOME GENE MUTATIONS LIKE BRCA1 OR BRCA2, BUT THERE’S ANOTHER ONE THAT YOU MAY NOT HAVE HEARD OF, AND IT’S CHEK2. MERCY MEDICAL CENTER DOCTOR NEIL FRIEDMAN JOINS US NOW ...

BREAST CANCER SURGERY. ACCORDING TO A GENETIC COUNSELOR AT MERCY MEDICAL CENTER, YOUR CHANCE OF DEVELOPING BREAST CANCER WITHOUT A FAMILY HISTORY OR NO OTHER SPECIAL CIRCUMSTANCE IS ABOUT 12%. THE ...

TOLEDO, Ohio — Breast cancer is the second leading cause of cancer death among women in the U.S., behind only lung cancer, according to the Centers for Disease Control and Prevention. October marks ...

A new drug combo is more effective in treating advanced prostate cancer The targeted drug niraparib added to hormone therapy slowed cancer growth and symptom progression Signs show the combo might ...

NEWPORT, Wales — Primary care doctors across the UK remain uncertain about how best to test, counsel, and refer men for suspected prostate cancer, particularly those at higher risk, experts warned at ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous form of prostate cancer in men who have specific mutations in DNA repair ...